Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2003
08/21/2003CA2473586A1 Treatment of sleep disorders using sleep target modulators
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2472763A1 5-ht2b receptor antagonists
08/21/2003CA2472762A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003CA2462688A1 Partial dopamine-d2 receptor agonist plus serotonin and/or noradrenaline inhibitor activity
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/20/2003EP1336608A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1336413A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
08/20/2003EP1336411A1 Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
08/20/2003EP1336406A1 Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity
08/20/2003EP1335937A2 Mixed fibrils
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335921A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
08/20/2003EP1335920A2 Small molecule compositions for binding to hsp90
08/20/2003EP1335919A1 Novel compounds
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335915A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/20/2003EP1335912A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
08/20/2003EP1335908A2 Peroxisome proliferator activated receptor alpha agonists
08/20/2003EP1335906A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
08/20/2003EP1335902A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1335895A2 Protease inhibitors and their pharmaceutical uses
08/20/2003EP1335747A1 A composition of sodium channel blocking compound
08/20/2003EP1335746A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
08/20/2003EP1335738A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
08/20/2003EP1335736A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders
08/20/2003EP1335733A1 Treatment of osteoporosis
08/20/2003EP1335731A2 Antidiabetic compositions containing a biguanide and a sulfonamide
08/20/2003EP1335726A1 Modified prodrug forms of ap/amp
08/20/2003EP1335720A1 Sulphonamides for the treatment of central nervous system diseases
08/20/2003EP1335718A1 6-methoxy-2-naphthylacetic acid prodrugs
08/20/2003EP1335716A1 Novel use of combined 5-ht 1a agonists and selective serotonin reuptake inhibitors
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1263504B1 Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina
08/20/2003EP1254139B1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1165542B1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1075258B1 Novel fatty analogues for the treatment of obesity
08/20/2003EP1067935B1 Acylbenzoxazines for enhancing synaptic response(s)
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP1047711B1 Nucleic acid sequences encoding capsaicin receptors
08/20/2003EP0966295B1 Calcareous material
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003EP0799040B1 Trisubstituted thioxanthines
08/20/2003EP0697886B1 New peptide antagonists at glutamate and nmda receptors
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437600A Pyrroloquinolones as antiviral agents
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437598A Novel indole derivatives
08/20/2003CN1437597A Substituted phenyl-Piperazine derivatives, their preparation and use
08/20/2003CN1437595A Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437588A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type l
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437581A Glucagon antagonists/inverse agonists
08/20/2003CN1437486A Stabiliser for radiopharmaceuticals
08/20/2003CN1437485A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
08/20/2003CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent
08/20/2003CN1437477A A Memory enhancing protein
08/20/2003CN1437476A Optimized minigenes and peptides encoded thereby
08/20/2003CN1437474A Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase Ôàáand Ôàí inhibitors
08/20/2003CN1437469A Solid valsartan pharmaceutical composition
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1437466A Methods for pulmonary delivery of interleukin-2
08/20/2003CN1436537A Oral liquid with hyaluronic acid as effective component
08/20/2003CN1118571C Active protein with thrombopoietin
08/20/2003CN1118475C Cyclopeptide derivatives
08/20/2003CN1118468C Pyrazolopyrimidines and pyrazolotriazines
08/20/2003CN1118467C 1,3,8-triaza-spiro [4,5] decan-4-on derivatives
08/20/2003CN1118459C Pyrimidinedione, pyrimidi netrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-adrenergic receptor antagonists
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/20/2003CN1118454C Heterocyclic derivative and medicine
08/20/2003CN1118451C Acylated derivatives of melatonin and its analogues as medicine
08/20/2003CN1118298C Health product instant granules and producing method thereof
08/20/2003CN1118295C Chinese herb medicine composition with kidney-reinforcing and blood circulation-promoting function
08/20/2003CN1118282C Method for preparing calcium replenishing liquid with composite function
08/19/2003WO2003070947A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608218 Such as 1-(cyclopentyloxy-(3,4-dichloro-phenyl)-acetyl)-3-methyl-urea for treatment of diabetes
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608108 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
08/19/2003US6608107 Administering gossypol; kits to treat patients
08/19/2003US6608105 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608100 HIV protease inhibitors based on amino acid derivatives
1 ... 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 ... 1564